These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25174441)

  • 41. The value of antegrade stenting for lower ureteric obstruction.
    Jenkins CN; Marcus AJ
    J R Soc Med; 1995 Aug; 88(8):446-9. PubMed ID: 7562827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Endoluminal therapy for bilateral malignant ureteric obstruction].
    Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic incision for obstruction of vesico-ureteric anastomosis in transplanted kidneys.
    He Z; Li X; Chen L; Zeng G; Yuan J; Chen W; Zhang C
    BJU Int; 2008 Jul; 102(1):102-6. PubMed ID: 18341628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laser lithotripsy for ureteric calculi: results in 250 patients.
    Kelly JD; Keane PF; Johnston SR; Kernohan RM
    Ulster Med J; 1995 Oct; 64(2):126-30. PubMed ID: 8533176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double pigtail ureteric stent versus percutaneous nephrostomy: effects on stone transit and ureteric motility.
    Lennon GM; Thornhill JA; Grainger R; McDermott TE; Butler MR
    Eur Urol; 1997; 31(1):24-9. PubMed ID: 9032530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of retrograde pyelography for infected ureteral stones.
    Palka J; Farooq Z; Anderson BG
    Can J Urol; 2020 Feb; 27(1):10130-10134. PubMed ID: 32065871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Percutaneous urinary drainage and ureteric stenting in malignant disease.
    Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
    Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ureteroscopic management of sepsis associated with ureteral stone impaction: is it still contraindicated?
    Hsu JM; Chen M; Lin WC; Chang HK; Yang S
    Urol Int; 2005; 74(4):319-22. PubMed ID: 15897696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stone formation on ureteric stents in children.
    MacKinnon AE; Ozuzurs B
    Br J Urol; 1991 Oct; 68(4):431-3. PubMed ID: 1933170
    [No Abstract]   [Full Text] [Related]  

  • 51. Endoscopic retrograde stenting for allograft hydronephrosis.
    Sigman DB; Del Pizzo JJ; Sklar GN
    J Endourol; 1999 Feb; 13(1):21-5. PubMed ID: 10102123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Choosing the best way for urinary decompression and developing a novel predictive model for septic shock using SOFA in these patients.
    Law YXT; Shen L; Khor VWS; Chen W; Chen WJK; Durai P; Gauhar V; Lie KY; Lee KCJ
    Int J Urol; 2022 Dec; 29(12):1488-1496. PubMed ID: 36070249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ureteral obstruction: is the full metallic double-pigtail stent the way to go?
    Liatsikos E; Kallidonis P; Kyriazis I; Constantinidis C; Hendlin K; Stolzenburg JU; Karnabatidis D; Siablis D
    Eur Urol; 2010 Mar; 57(3):480-6. PubMed ID: 19232816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of antegrade stenting in the management of the obstructed kidney.
    Sharma SD; Persad RA; Haq A; Appleton DS; Doyle PT; Bullock KN; Doble A
    Br J Urol; 1996 Oct; 78(4):511-5. PubMed ID: 8944505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The management of ureteric obstruction secondary to malignant pelvic disease.
    Chitale SV; Scott-Barrett S; Ho ET; Burgess NA
    Clin Radiol; 2002 Dec; 57(12):1118-21. PubMed ID: 12475538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
    Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
    J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endourologic management of severely encrusted ureteral stents.
    Lojanapiwat B
    J Med Assoc Thai; 2005 Sep; 88(9):1203-6. PubMed ID: 16536105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of early ureteric stenting for urosepsis associated with urinary tract calculi.
    Nishiguchi S; Branch J; Suganami Y; Kitagawa I; Tokuda Y
    Intern Med; 2014; 53(19):2205-10. PubMed ID: 25274231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
    Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
    Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One- vs 4-week stent placement after laparoscopic and robot-assisted pyeloplasty: results of a prospective randomised single-centre study.
    Danuser H; Germann C; Pelzer N; Rühle A; Stucki P; Mattei A
    BJU Int; 2014 Jun; 113(6):931-5. PubMed ID: 24472002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.